Crohnâs and Colitis Canada (CCC) was founded in 1974 by a group of parents whose children were diagnosed with inflammatory bowel disease (IBD). They were concerned about the lack of funding for IBD research and they were interested in learning more about Crohnâs disease and ulcerative colitis.
From that small but dedicated group, CCC has grown to become a world leader in IBD research funding. Crohnâs and Colitis Canada is the countryâs largest non-governmental funder of Crohnâs and colitis research and is the single largest patient organization in Canada focused on Crohnâs disease and ulcerative colitis, with over 40 volunteer chapters across the country.
Through the support of its generous sponsors and donors, CCC funds research projects that probe the mysteries of IBD. Life-altering treatments have been developed as a result of these discoveries, and, one day, a cure will be found.
Awards
2013
Recipient
Vijay MorampudiAward type
Research Trainee award
Project title
Do goblet cell mediators co-operatively prevent gut microbiota from causing spontaneous colitis?
2011
Recipient
Yanet ValdezAward type
Research Trainee award
Project title
Dissecting the role of CD248 in inflammatory diseases
2009
Recipient
Marta WlodarskaAward type
Research Trainee award
Project title
The role of microbiota in susceptibility to inflammatory bowel disease.
Recipient
Megan HimmelAward type
Research Trainee award
Project title
Functional characterization of T cells and T regulatory cells in Inflammatory Bowel Disease